[Direct and indirect treatment cost of patient with ischaemic heart disease].
Authors of this paper attempted to evaluate the cost of treatment of hypothetical patient with ischaemic heart disease during the period 16 years. The medical costs (costs of medicines, diagnostic procedures, coronary angioplasty and bypass surgery) and indirect costs of lost productivity have been estimated.
Maciag
Agnieszka
A
Zakład Organizacji i Ekonomiki Ochrony Zdrowia oraz Szpitalnictwa, Narodowy Instytut Zdrowia Publicznego-Państwowy Zakład Higieny, Warszawa. amaciag@pzh.gov.pl
Wysocki
Mirosław J
MJ
Bak
Marianna I
MI
D015906:Angioplasty, Balloon, Coronary / Q000191:economics; D001026:Coronary Artery Bypass / Q000191:economics; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D004180:Direct Service Costs / Q000706:statistics & numerical data; D016527:Drug Costs / Q000706:statistics & numerical data; D017721:Hospital Costs / Q000706:statistics & numerical data; D006801:Humans; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000191:economics* / Q000628:therapy*; D005791:Patient Care / Q000191:economics* / Q000706:statistics & numerical data; D011044:Poland; D011306:Prescription Fees / Q000706:statistics & numerical data